Vericel (VCEL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VCEL Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Vericel's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent109.30
Short-term Investments, Total36.05
Cash & Short-term Investments145.00
Accounts receivable72.38
Inventories18.35
Other Current Assets7.99
Total Current Assets244.06
Intangible Assets5.47
Long-term investments65.28
Other Assets, Noncurrent170.81
Restricted Cash Current-
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization107.11
Operating Lease Right Of Use Asset63.41
Total Assets485.63
Liabilities
Accounts Payable, Current AC19.01
Accrued Liabilities, Current AC13.97
Other Liabilities, Current14.18
Total Current Liabilities47.16
Total Long-term Debt0.00
Other liabilities, Noncurrent82.24
Operating Lease Liability Current14.06
Operating Lease Liability Noncurrent80.36
Total Liabilities129.40
Stockholders' Equity
Common Stock Value739.00
Retained Earnings / Accumulated Deficit-382.60
Other Equity-0.17
Common Stockholder's Equity356.23
Total Stockholder's Equity356.23
Liabilities & Stockholder's Equity485.63
4 historic quarters locked

Sign in to unlock the full Vericel balance sheet history.

About Vericel Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-050836

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.